A new study published in the journal Diabetes Technology & Therapeutics has evaluated the use of tirzepatide in overweight/obese adults with type 1 diabetes. Tirzepatide is approved for managing type 2 diabetes. It improves glucose control, facilitates weight loss, and improves cardiovascular disease outcomes.
Efficacy and safety of tirzepatide in overweight and obese individuals with type 1 diabetes retrieved 25 March 2024 from https://medicalxpress.com/news/2024-03-efficacy-safety-tirzepatide-overweight-obese.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Oct 2, 2023 Mounjaro: Type 2 diabetes drug more effective than Ozempic to launch in the UK—here's what you need to knowUse this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Study evaluates the use of tirzepatide in overweight/obese adults with type 1 diabetesA new study in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT) evaluated the use of tirzepatide in overweight/obese adults with type 1 diabetes.
Read more »
Researchers use algorithm to provide innovative insights into the heterogeneity of type 2 diabetesA landmark study by the German Diabetes Center (DDZ), published in The Lancet Diabetes & Endocrinology, sheds new light on the heterogeneity of type 2 diabetes. The researchers have employed an innovative algorithm to stratify people with type 2 diabetes using routine data and thus visualize the metabolic diversity of diabetes.
Read more »
Study sheds new light on the heterogeneity of type 2 diabetesA landmark study by the German Diabetes Center (DDZ), published in The Lancet Diabetes & Endocrinology, sheds new light on the heterogeneity of type 2 diabetes.
Read more »
Point-of-care therapeutics sensor could make automated dosing systems universalRice University synthetic biologists have found a way to piggyback on the glucose monitoring technology used in automated insulin dosing systems and make it universally applicable for the monitoring and dosing of virtually any drug.
Read more »
New vaccine against fatal tropical disease and potential bioterror weapon demonstrates efficacy in animal studiesIn a mouse study, UCLA researchers tested a vaccine against the bacterium that causes melioidosis and found it was highly protective against the disease, which is endemic in many tropical areas, causing approximately 165,000 cases with 89,000 fatalities around the world each year.
Read more »
Enhancing the safety and efficacy of breast and ovarian cancer treatmentSome anti-cancer treatments not only target tumour cells but also healthy cells. If their effects on the latter are too strong, their use can become limiting.
Read more »